跳至主要内容
临床试验/ACTRN12608000072314
ACTRN12608000072314招募中未知

Bare Metal Bifurcation Stent Clinical Trial in Humans (IP088) - Safety at 30 Days

Medtronic Vascular0 个研究点目标入组 60 人开始时间: 2008年2月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 /A(—)
性别
All

入选标准

  • Patient is =/> 18 years old
  • Acceptable candidate for Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Graft (CABG)
  • Clinical evidence of ischemic heart disease
  • Female patients with negative pregnancy test
  • Informed Consent Obtained
  • Agrees to comply with follow-up evaluations
  • Single de novo bifurcation lesion in a native coronary artery with specific dimensions
  • Stenosis =/> 50% and < 100%
  • Thrombolysis in Myocardial Infarction (TIMI) flow =/> 2

排除标准

  • Hypersensitivity or contraindication to aspirin, heparin or bivalirudin, clopidogrel or ticlopidine, cobalt, nickel, chromium, molybdenum
  • Platelet count < 100,000 cells/mm3 or > 700,000 cells/mm3
  • WBC < 3,000 cells/mm3
  • Serum creatinine level > 170 micromol/L
  • Evidence of MI within 72 hours of intended trial procedure
  • Previous stenting in Target Vessel
  • LVEF < 30%
  • History of stroke or TIA within 6 months
  • History of bleeding diathesis or coagulopathy or refusal of blood transfusion
  • Specific target lesion morphology

研究者

发起方
Medtronic Vascular

相似试验

Bare Metal BifuRcAtion SteNt Clinical Trial in... | 临床试验